Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Managing dose-, damage- and data-rates in multi-frame spectrum-imaging.

Jones L, Varambhia A, Beanland R, Kepaptsoglou D, Griffiths I, Ishizuka A, Azough F, Freer R, Ishizuka K, Cherns D, Ramasse QM, Lozano-Perez S, Nellist PD.

Microscopy (Oxf). 2018 Mar 1;67(suppl_1):i98-i113. doi: 10.1093/jmicro/dfx125.

PMID:
29340597
2.

Prospects for Engineering Thermoelectric Properties in La1/3NbO3 Ceramics Revealed via Atomic-Level Characterization and Modeling.

Kepaptsoglou D, Baran JD, Azough F, Ekren D, Srivastava D, Molinari M, Parker SC, Ramasse QM, Freer R.

Inorg Chem. 2018 Jan 2;57(1):45-55. doi: 10.1021/acs.inorgchem.7b01584. Epub 2017 Dec 19.

PMID:
29257680
3.

Concurrent La and A-Site Vacancy Doping Modulates the Thermoelectric Response of SrTiO3: Experimental and Computational Evidence.

Azough F, Jackson SS, Ekren D, Freer R, Molinari M, Yeandel SR, Panchmatia PM, Parker SC, Maldonado DH, Kepaptsoglou DM, Ramasse QM.

ACS Appl Mater Interfaces. 2017 Dec 6;9(48):41988-42000. doi: 10.1021/acsami.7b14231. Epub 2017 Nov 27.

PMID:
29134804
4.

Bim gene dosage is critical in modulating nephron progenitor survival in the absence of microRNAs during kidney development.

Cerqueira DM, Bodnar AJ, Phua YL, Freer R, Hemker SL, Walensky LD, Hukriede NA, Ho J.

FASEB J. 2017 Aug;31(8):3540-3554. doi: 10.1096/fj.201700010R. Epub 2017 Apr 26.

PMID:
28446592
5.

Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS.

Ciryam P, Lambert-Smith IA, Bean DM, Freer R, Cid F, Tartaglia GG, Saunders DN, Wilson MR, Oliver SG, Morimoto RI, Dobson CM, Vendruscolo M, Favrin G, Yerbury JJ.

Proc Natl Acad Sci U S A. 2017 May 16;114(20):E3935-E3943. doi: 10.1073/pnas.1613854114. Epub 2017 Apr 10.

6.

Tuning the thermoelectric properties of A-site deficient SrTiO3 ceramics by vacancies and carrier concentration.

Srivastava D, Norman C, Azough F, Schäfer MC, Guilmeau E, Kepaptsoglou D, Ramasse QM, Nicotra G, Freer R.

Phys Chem Chem Phys. 2016 Sep 29;18(38):26475-26486.

PMID:
27711621
7.

A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer's disease.

Freer R, Sormanni P, Vecchi G, Ciryam P, Dobson CM, Vendruscolo M.

Sci Adv. 2016 Aug 10;2(8):e1600947. doi: 10.1126/sciadv.1600947. eCollection 2016 Aug.

8.

Non-rigid registration and non-local principle component analysis to improve electron microscopy spectrum images.

Yankovich AB, Zhang C, Oh A, Slater TJ, Azough F, Freer R, Haigh SJ, Willett R, Voyles PM.

Nanotechnology. 2016 Sep 9;27(36):364001. doi: 10.1088/0957-4484/27/36/364001. Epub 2016 Aug 1.

PMID:
27479946
9.

Facile Surfactant-Free Synthesis of p-Type SnSe Nanoplates with Exceptional Thermoelectric Power Factors.

Han G, Popuri SR, Greer HF, Bos JW, Zhou W, Knox AR, Montecucco A, Siviter J, Man EA, Macauley M, Paul DJ, Li WG, Paul MC, Gao M, Sweet T, Freer R, Azough F, Baig H, Sellami N, Mallick TK, Gregory DH.

Angew Chem Int Ed Engl. 2016 May 23;55(22):6433-7. doi: 10.1002/anie.201601420. Epub 2016 Apr 20.

10.

A transcriptional signature of Alzheimer's disease is associated with a metastable subproteome at risk for aggregation.

Ciryam P, Kundra R, Freer R, Morimoto RI, Dobson CM, Vendruscolo M.

Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4753-8. doi: 10.1073/pnas.1516604113. Epub 2016 Apr 11.

11.

Tungsten Bronze Barium Neodymium Titanate (Ba(6-3n)Nd(8+2n)Ti(18)O(54)): An Intrinsic Nanostructured Material and Its Defect Distribution.

Azough F, Cernik RJ, Schaffer B, Kepaptsoglou D, Ramasse QM, Bigatti M, Ali A, MacLaren I, Barthel J, Molinari M, Baran JD, Parker SC, Freer R.

Inorg Chem. 2016 Apr 4;55(7):3338-50. doi: 10.1021/acs.inorgchem.5b02594. Epub 2016 Mar 21.

PMID:
26998674
12.

Crystal structure and thermoelectric properties of Sr-Mo substituted CaMnO3: a combined experimental and computational study.

Srivastava D, Azough F, Freer R, Combe E, Funahashi R, Kepaptsoglou DM, Ramasse QM, Molinari M, Yeandel SR, Baran JD, Parker SC.

J Mater Chem C Mater. 2015 Dec 21;3(47):12245-12259. doi: 10.1039/c5tc02318a. Epub 2015 Nov 13.

13.

Thermoelectric Power Generation from Lanthanum Strontium Titanium Oxide at Room Temperature through the Addition of Graphene.

Lin Y, Norman C, Srivastava D, Azough F, Wang L, Robbins M, Simpson K, Freer R, Kinloch IA.

ACS Appl Mater Interfaces. 2015 Jul 29;7(29):15898-908. doi: 10.1021/acsami.5b03522. Epub 2015 Jul 20.

PMID:
26095083
14.

Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer.

Elattar A, Warburton KG, Mukhopadhyay A, Freer RM, Shaheen F, Cross P, Plummer ER, Robson CN, Edmondson RJ.

Gynecol Oncol. 2012 Jan;124(1):142-7. doi: 10.1016/j.ygyno.2011.09.004. Epub 2011 Oct 15.

PMID:
22001143
15.

Students helping students.

Isles P, Freer R.

Nurs N Z. 1999 Jun;5(5):18-9. No abstract available.

PMID:
10687602
16.

Human rights in the USA: land of the free?

Freer R.

Lancet. 1998 Dec 5;352(9143):1853-4. No abstract available.

PMID:
9851404
17.

Strategies for positioning fluorescent probes and crosslinkers on formyl peptide ligands.

Vilven JC, Domalewski M, Prossnitz ER, Ye RD, Muthukumaraswamy N, Harris RB, Freer RJ, Sklar LA.

J Recept Signal Transduct Res. 1998 Mar-May;18(2-3):187-221.

PMID:
9651885
18.

C5aR ligand peptide 3D QSAR study performed with an applied linear conformation.

Anderson CY, Kellogg GE, Freer RJ.

J Pept Res. 1997 Jun;49(6):476-83.

PMID:
9266474
19.

Fixation traps formyl peptide receptors in high and low affinity forms that can be regulated by GTP[S] in the absence of ligand.

Domalewski MD, Guyer DA, Freer RJ, Muthukumaraswamy N, Sklar LA.

J Recept Signal Transduct Res. 1996 Jan-Mar;16(1-2):59-75.

PMID:
8771531
20.

A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor.

Gao JL, Becker EL, Freer RJ, Muthukumaraswamy N, Murphy PM.

J Exp Med. 1994 Dec 1;180(6):2191-7.

21.

The effect of perioperative blood transfusion on survival in head and neck cancer.

Schuller DE, Scott C, Wilson KM, Freer R, al-Sarraf M, Jacobs J, Ahmad K, Casiano R, Laramore G.

Arch Otolaryngol Head Neck Surg. 1994 Jul;120(7):711-6.

PMID:
8018322
22.

Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI.

Kohn EC, Felder CC, Jacobs W, Holmes KA, Day A, Freer R, Liotta LA.

Cancer Res. 1994 Feb 15;54(4):935-42.

PMID:
8313384
23.

Multiparameter flow cytometric analysis of a pH sensitive formyl peptide with application to receptor structure and processing kinetics.

Fay SP, Habbersett R, Domalewski MD, Posner RG, Houghton TG, Pierson E, Muthukumaraswamy N, Whitaker J, Haugland RP, Freer RJ, et al.

Cytometry. 1994 Feb 1;15(2):148-53.

24.
26.

Conformational dynamics of the formyl peptide receptor: a prototype for studies of receptor dynamics and binding pocket structure.

Sklar LA, Fay SP, Mueller H, Freer RJ, Muthukumaraswamy N, Magde D.

Agents Actions Suppl. 1991;35:11-6. Review.

PMID:
1781416
28.

Fluorescence analysis of the size of a binding pocket of a peptide receptor at natural abundance.

Sklar LA, Fay SP, Seligmann BE, Freer RJ, Muthukumaraswamy N, Mueller H.

Biochemistry. 1990 Jan 16;29(2):313-6.

PMID:
2105739
29.

Conformationally restricted formyl methionyl tripeptide chemoattractants: a three-dimensional structure-activity study of analogs incorporating a C alpha,alpha-dialkylated glycine at position 2.

Toniolo C, Crisma M, Valle G, Bonora GM, Polinelli S, Becker EL, Freer RJ, Sudhanand, Rao RB, Balaram P, et al.

Pept Res. 1989 Jul-Aug;2(4):275-81.

PMID:
2520765
30.

Thermal regulation of FMLP receptors on human neutrophils.

Coles RB, Ranney RR, Freer RJ, Carchman RA.

J Leukoc Biol. 1989 Jun;45(6):529-37.

PMID:
2723537
31.

A computergraphic determination of the chemotactic peptide preferred conformation.

Semus SF, Becker EL, Toniolo C, Freer RJ.

Biochem Biophys Res Commun. 1988 Dec 15;157(2):569-74.

PMID:
3202870
32.

Synthetic formyl-methionyl chemoattractants: a conformation-activity study of oxidized tripeptides.

Toniolo C, Bonora GM, Freer RJ, Kennedy SP, Pittenger KL, Becker EL.

Peptides. 1988 Nov-Dec;9(6):1195-205.

PMID:
3247246
34.

Synthesis of chemotactic peptides.

Muthukumaraswamy N, Freer RJ.

Methods Enzymol. 1988;162:132-9. No abstract available.

PMID:
3226301
35.
36.

Synthetic homo-oligomethionine chemoattractants. Conformation-activity study.

Bismara C, Bonora GM, Toniolo C, Becker EL, Freer RJ.

Int J Pept Protein Res. 1985 Nov;26(5):482-92.

PMID:
4086165
37.

Secretagogue-induced phosphoinositide metabolism in human leucocytes.

Dougherty RW, Godfrey PP, Hoyle PC, Putney JW Jr, Freer RJ.

Biochem J. 1984 Sep 1;222(2):307-14.

38.
39.

Structural requirements for formyl homooligopeptide chemoattractants.

Toniolo C, Bonora GM, Showell H, Freer RJ, Becker EL.

Biochemistry. 1984 Feb 14;23(4):698-704.

PMID:
6712920
40.

Conformationally constrained chemotactic peptide analogs of high biological activity.

Iqbal M, Balaram P, Showell HJ, Freer RJ, Becker EL.

FEBS Lett. 1984 Jan 9;165(2):171-4.

41.

Evaluation of opioid receptor heterogeneity in isolated, field stimulated rat ileum.

Liao CS, Freer RJ.

Proc West Pharmacol Soc. 1984;27:439-42. No abstract available.

PMID:
6093138
42.
43.

Selective ligands for opioid receptors. beta-Cyclopropylalanyl containing analogs of enkephalin.

Muthukumaraswamy N, Day AR, Pinon D, Liao CS, Freer RJ.

Int J Pept Protein Res. 1983 Sep;22(3):305-12. No abstract available.

PMID:
6313538
44.

Characterization of the rat neutrophil formyl peptide chemotaxis receptor.

Marasco WA, Fantone JC, Freer RJ, Ward PA.

Am J Pathol. 1983 Jun;111(3):273-81.

45.

Evidence for a single opioid receptor type on the rat deferens.

Freer RJ, Day AR, Liao CS.

NIDA Res Monogr. 1982 Apr;41:172-7. No abstract available.

PMID:
6289116
46.

Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.

Marasco WA, Showell HJ, Freer RJ, Becker EL.

J Immunol. 1982 Feb;128(2):956-62.

PMID:
7033385
47.

Formyl peptide chemoattractants: a model of the receptor on rabbit neutrophils.

Freer RJ, Day AR, Muthukumaraswamy N, Pinon D, Wu A, Showell HJ, Becker EL.

Biochemistry. 1982 Jan 19;21(2):257-63. No abstract available.

PMID:
6280748
48.

Evidence for a single opioid receptor type on the field stimulated rat vas deferens.

Liao CS, Day AR, Freer RJ.

Life Sci. 1981 Dec 21;29(25):2617-22. No abstract available.

PMID:
6119598
49.

N alpha-formyl-norleucyl-leucyl-phenylalanyl chloromethylketone. A possible covalent agonist of the N alpha-formyl-methionyl-peptide receptor.

Showell HJ, Mackin WM, Becker EL, Muthukumarasway N, Day AR, Freer R.

Mol Cell Biochem. 1981 Dec 4;41:19-25.

PMID:
6276716
50.

Morphiceptin ( beta-casomorphin (1-4) amide): a peptide opioid antagonist in the field stimulated rat vas deferens.

Day AR, Freer RJ, Liao CS.

Res Commun Chem Pathol Pharmacol. 1981 Dec;34(3):543-6.

PMID:
6275472

Supplemental Content

Support Center